Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.58 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.58 |
| ▸ | CYP1A1 | P04798 | 5/20 | 0.56 |
| ▸ | CYP1B1 | Q16678 | 5/20 | 0.56 |
| ▸ | NQO2 | P16083 | 4/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.46 |
| ▸ | ESR1 | P03372 | 2/20 | 0.46 |
| ▸ | ABL1 | P00519 | 2/20 | 0.46 |
| ▸ | TTR | P02766 | 2/20 | 0.46 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.46 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.46 |
| ▸ | BCR | P11274 | 2/20 | 0.46 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.46 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.46 |
| ▸ | TUBB | P07437 | 1/20 | 0.46 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.46 |
| ▸ | AHR | P35869 | 1/20 | 0.46 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL228003 | 0.95 | CYP1A1 (0.64) | ALDH1A1CYP2A6CYP1A1CYP1B1NQO2 | |
| Water SCHEMBL28227114 | 0.92 | CYP1A1 (0.61) | ALDH1A1CYP2A6CYP1A1CYP1B1NQO2 | |
| SCHEMBL5883123 | 0.89 | ALDH1A1 (0.48) | ALDH1A1CYP2A6CYP1A1CYP1B1NQO2 | |
| Formic Acid Methyl Ester SCHEMBL28071788 | 0.88 | CYP1A1 (0.56) | ALDH1A1CYP2A6CYP1A1CYP1B1NQO2 | |
| SCHEMBL5883210 | 0.87 | CYP1A1 (0.56) | ALDH1A1CYP2A6CYP1A1CYP1B1NQO2 | |
| SCHEMBL5883214 | 0.87 | CYP1A1 (0.56) | ALDH1A1CYP2A6CYP1A1CYP1B1NQO2 | |
| SCHEMBL14536306 | 0.86 | CYP2A6 (0.50) | ALDH1A1CYP2A6CYP1A1CYP1B1NQO2 | |
| SCHEMBL29958196 | 0.86 | CYP1A1 (0.58) | ALDH1A1CYP2A6CYP1A1CYP1B1NQO2 | |
| SCHEMBL29951799 | 0.86 | ALDH1A1 (0.50) | ALDH1A1CYP2A6CYP1A1CYP1B1NQO2 | |
| SCHEMBL378297 | 0.86 | CYP1A1 (0.58) | ALDH1A1CYP2A6CYP1A1CYP1B1NQO2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3947344-B1 | 2,2'-(1,3-PHENYLENEDIMETHYLIDYNE)-BIS-HYDRAZINECARBOXIMIDAMIDE DERIVATIVES AS RETROMER STABILIZERS FOR THE TREATMENT OF NEUROLOGICAL DISEASES | OSPEDALE SAN RAFFAELE SRL (IT) | 2025-10-01 | — | — | EP | disclosed |
| US-20240166867-A1 | THERMOPLASTIC RESIN AND OPTICAL LENS INCLUDING SAME | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2024-05-23 | — | — | US | disclosed |
| EP-4286448-A1 | THERMOPLASTIC RESIN AND OPTICAL LENS INCLUDING SAME | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2023-12-06 | — | — | EP | disclosed |
| CN-114341103-B | Aminoguanhydrazones as retrograde transport stabilizers useful in the treatment of neurological diseases | 圣拉斐尔医院有限公司 | 2023-11-10 | — | — | CN | disclosed |
| CN-116940559-A | Cyclic diol compound, process for producing the compound, and use of the compound | 新日本理化株式会社 | 2023-10-24 | — | — | CN | disclosed |
| CN-116829618-A | Thermoplastic resin and optical lens comprising the same | 三菱瓦斯化学株式会社 | 2023-09-29 | — | — | CN | disclosed |
| US-20230178848-A1 | ELECTRODE SEPARATORS | UNIV KING ABDULLAH SCI & TECH (SA) | 2023-06-08 | — | — | US | disclosed |
| US-20220340893-A1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | NUEVOLUTION A/S (DK) | 2022-10-27 | — | — | US | disclosed |
| WO-2022163674-A1 | THERMOPLASTIC RESIN AND OPTICAL LENS INCLUDING SAME | 三菱瓦斯化学株式会社 | 2022-08-04 | — | — | WO | disclosed |
| WO-2022163684-A1 | CYCLIC DIOL COMPOUND, METHOD FOR PRODUCING SAID COMPOUND, AND USE OF SAID COMPOUND | 新日本理化株式会社 | 2022-08-04 | — | — | WO | disclosed |
| EP-1149069-A1 | PHENYLGLYCINE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2001-10-31 | — | — | EP | disclosed |
| US-6242644-B1 | FOR TREATING THROMBOSIS, APOPLEXY, CARDIAC INFARCTION, INFLAMATION AND ARTHEROSCLEROSIS | HOFFMANN-LA ROCHE INC. | 2001-06-05 | — | — | US | disclosed |
| US-20010001799-A1 | N-(4- carbamimidoyl-phenyl) -glycine derivatives | ACKERMANN JEAN (CH) | 2001-05-24 | — | — | US | disclosed |
| WO-2000035858-A1 | PHENYLGLYCINE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2000-06-22 | — | — | WO | disclosed |
| US-5763681-A | ALPHA-2-ADAMANTYLIDENE-ALPHA-METHOXY-META-METHOXYTOLUENE AND RELATED COMPOUNDS AS INTERMEDIATES | TROPIX, INC. (US) | 1998-06-09 | — | — | US | disclosed |
| US-5225584-A | Phosphonate esters and trialkylsilyl phosphonate esters | TROPIX, INC. (US) | 1993-07-06 | — | — | US | disclosed |
| EP-0441948-A4 | SYNTHESIS OF STABLE, WATER-SOLUBLE CHEMILUMINESCENT 1,2-DIOXETANES AND INTERMEDIATES THEREFOR | — | 1992-06-03 | — | — | EP | disclosed |
| EP-0441948-A1 | SYNTHESIS OF STABLE, WATER-SOLUBLE CHEMILUMINESCENT 1,2-DIOXETANES AND INTERMEDIATES THEREFOR | TROPIX, INC. (US) | 1991-08-21 | — | — | EP | disclosed |
| WO-1991003479-A1 | SYNTHESIS OF STABLE, WATER-SOLUBLE CHEMILUMINESCENT 1,2-DIOXETANES AND INTERMEDIATES THEREFOR | TROPIX, INC. (US) | 1991-03-21 | — | — | WO | disclosed |
| US-4962203-A | ANTIASTHMATIC, ANTIALLERGENIC, ANTIINFLAMMATORY AND CYTOPROTECTIVE AGENTS | MERCK FROST CANADA, INC. (CA) | 1990-10-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010001799-A1 | N-(4- carbamimidoyl-phenyl) -glycine derivatives | GLRA1, NGLY1, GLS | ALDH1A1 2850/4885CYP2A6 3857/4885CYP1A1 2442/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.